A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors

Stopped The data from this study is no longer needed.

Conditions

• Neoplasms
• Colorectal Neoplasms
• Melanoma
• Pancreatic Neoplasms
• Sarcoma
• Ovarian Neoplasms
• Brain Neoplasms
• Thyroid Neoplasms
• Neuroendocrine Tumors
• Cholangiocarcinoma
• Salivary Gland Neoplasms
• Head and Neck Neoplasms
• Thyroid Cancer, Papillary
• Lymphoma, Large-Cell, Anaplastic
• Neoplasms by Site
• Respiratory Tract Neoplasms
• Thoracic Neoplasms
• Respiratory Tract Diseases
• Carcinoma, Bronchogenic
• Bronchial Neoplasms
• Intestinal Neoplasms
• Gastrointestinal Neoplasms
• Digestive System Neoplasms
• Digestive System Diseases
• Gastrointestinal Diseases
• Colonic Diseases
• Intestinal Diseases
• Central Nervous System

Interventions

• DRUG: Alectinib

Sponsor

Hoffmann-La Roche